Advisory Board, in partnership with Medtronic, recently held a webinar to discuss hospitals' new strategy agenda after Covid-19. Health systems across the world have had no shortage of challenges and hurdles to overcome in the last year. Many organizations viewed these challenges as an opportunity to make meaningful progress or adapt their strategic priorities. If you missed the live session, here are three takeaways to keep in mind as you plan your post-Covid-19 strategy:
Health systems can't ignore these disparities any longer and many have used this time to make meaningful change. For example, ProMedica created their own National Social Determinants of Health Institute. The Institute works across ProMedica's provider and payer arms to integrate health equity into all care delivery and payment models. The President of Social Determinants of Health (SDOH) leads the institute—the first position of its kind in the world. ProMedica started small in 2010 with a large focus on data-driven work. They partnered with EHR vendors to build out modules and screenings to capture information on 10 different risk factors to identify at-risk patients and proactively implement care plans.
We are moving away from five-year strategic plans to ones that are more dynamic, flexible, and use less information to make decisions. One Welsh System, Hywel Dda, took steps to modernize their strategy operations by creating an entirely new operating framework. They audited their build-up of overlapping priorities and objectives to create a clearer framework that consists of two different kinds of objectives: strategic objectives (i.e., lofty, future-focused goals) and planning objectives (i.e., tactical goals with clear sets of metrics). Their CEO described the six strategic objectives as smudges on the horizon while the 65 planning objectives were paddle strokes working towards bigger goals.
Hywel Dda also transformed their governance system, which now offers a clear, standardized path for allocating new responsibilities across different levels of the business. This process helped shift the organization from corporate accountability—in which the organization and its leaders assume fault if they fail to achieve strategic objectives—to personal accountability, in which each person along the hierarchy has a clear role to play and authority to make decisions and embrace their accountability.
Covid-19 has narrowly disrupted strategy, but broadly disrupted operations—affecting where and how customers access care. The opportunity and political will to shift care access points will diminish quickly, so executives should focus on three areas:
While it may be a new year, we know our health system partners will continue to struggle with a plethora of complex problems. We think the health system executive's post-Covid-19 playbook will have to encompass these priorities as we all adjust to a post-covid world. Medtronic and the Advisory Board partnered to deliver a series of webinars for hospital administrators specific to Covid-19. You can access all three webinars (from October, December, and January) via this link.
From primary to long-term care, all providers had to rapidly adopt their working models to prepare for surges in both Covid-19 and non-Covid-19 demand. Most jurisdictions avoided the worst-case scenarios and hospitals showed they could rapidly expand their bed capacity on short notice. Now looking forward, what are our expectations for the hospital?
Download the full slide deck from our recent webinar where we review both the experiences in various countries and their future plans to try to bring some clarity to this complex and wide-ranging question.
At Medtronic, we believe in the power of medical technology to improve lives. Seven decades ago, our co-founder invented the battery-powered pacemaker. Today, we are among the largest medical device companies in the world. With operations in 150 countries, our products treat 70 health conditions and include cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Our therapies help 72 million people a year and support our Mission to alleviate pain, restore health, and extend life.
This blog post is sponsored by Medtronic, an Advisory Board member organization. Representatives of Medtronic helped select the topics and issues addressed. Advisory Board experts wrote the post, maintained final editorial approval, and conducted the underlying research independently and objectively. Advisory Board does not endorse any company, organization, product or brand mentioned herein.
This blog post is sponsored by Medtronic. Advisory Board experts wrote the post, conducting the underlying research independently and objectively.
Create your free account to access 2 resources each month, including the latest research and webinars.
You have 2 free members-only resources remaining this month remaining this month.
Never miss out on the latest innovative health care content tailored to you.